Skip to content
All Podcasts – Lifestyle
Author:
Sunshine Biopharma Inc.
Galway Metals Reports High-Grade Gold Intercepts at Southwest Deposit Including 20.7 g/t Gold over 11.0 Meters
May 21, 2026
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin
May 21, 2026
Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering
May 19, 2026
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
May 18, 2026
Galway Metals Intersects 6.1 g/t Gold over 19.0m Including 18.3 g/t over 3.0m
April 23, 2026
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
April 6, 2026
←
Previous Page
1
2